If you have been reading about nuclear receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
== Clinical significance in humans == Eccentric hypertrophy is a type of hypertrophy in which the walls and chamber of a hollow organ undergo growth, resulting in an overall increase in size and volume. It is most commonly described in the left ventricle of the heart. Sarcomeres are added in series, as for example in dilated cardiomyopathy (in contrast to hypertrophic cardiomyopathy, a type of concentric hypertrophy, where sarcomeres are added in parallel).
E0: normal ear E1: Minor hypoplasia and cupping with all structures present E2: Absence of external auditory canal with variable hypoplasia of the auricle E3: Malposition of the lobule with absent auricle, lobular remnant usually inferior anteriorly displaced Facial nerve
==== Metal-free organic cavity modifiers ==== Most examples of MOF-based catalysis make use of metal ions or atoms as active sites. Among the few exceptions are two nickel- and two copper-containing MOFs synthesized by Rosseinsky and co-workers. These compounds employ amino acids (L- or D-aspartate) together with dipyridyls as struts. The coordination chemistry is such that the amine group of the aspartate cannot be protonated by added HCl, but one of the aspartate carboxylates can. Thus, the framework-incorporated amino acid can exist in a form that is not accessible for the free amino acid. While the nickel-based compounds are marginally porous, on account of tiny channel dimensions, the copper versions are clearly porous. The Rosseinsky group showed that the carboxylic acids behave as Brønsted acidic catalysts, facilitating (in the copper cases) the ring-opening methanolysis of a small, cavity-accessible epoxide at up to 65% yield. Superior homogeneous catalysts exist however. Kitagawa and co-workers have reported the synthesis of a catalytic MOF having the formula [Cd(4-btapa)2(NO3)2]. The MOF is three-dimensional, consisting of an identical catenated pair of networks, yet still featuring pores of molecular dimensions. The nodes consist of single cadmium ions, octahedrally ligated by pyridyl nitrogens. From a catalysis standpoint, however, the most interesting feature of this material is the presence of guest-accessible amide functionalities. The amides are capable of base-catalyzing the Knoevenagel condensation of benzaldehyde with malononitrile.
Despite the fact that consistories in Freemasonry are only meant to administer the higher degrees, the Consistory believed it had authority to manage the Blue Lodges. The Supreme Council, despite being designed to administer the 33rd degree, had started chartering new Lodges without consulting the Grand Lodge of Colon. On May 22, 1860, Restauracion Lodge No. 4 was chartered in Jiguaní. In 1861, Amor Fraternal No. 5, Segunda Prudencia No. 6, and Dicipulos de Salomon No. 7 were chartered. In 1862, Fe Masonica Lodge was formed in Havana by members of Amor Fraternal.
=== Dentition === Komodo dragons have ziphodont teeth, which are defined as teeth that are laterally flattened, recurved, and with serrated tooth crowns where the serrations have a dentine core and a very thin enamel outer layer. This is the same type of dentition observed in many extinct theropod dinosaurs. The teeth of the insectivorous juveniles in contrast are barely recurved, with fewer and less well-developed serrations that lack dentine cores.
Sources: en.wikipedia.org
=== Analogues === 3,4-DMA is an analogue of the catecholamine neurotransmitters dopamine (3,4-dihydroxyphenethylamine), norepinephrine (noradrenaline; 3,4,β-trihydroxyphenethylamine), and epinephrine (adrenaline; 3,4,β-trihydroxy-N-methylphenethylamine). It is also an analogue of psychedelics and entactogens like mescaline (3,4,5-trimethoxyphenethylamine), 3,4,5-trimethoxyamphetamine (TMA), and 3,4-methylenedioxyamphetamine (MDA), among others. Positional isomers of 3,4-DMA include 2,3-dimethoxyamphetamine (2,3-DMA), 2,4-dimethoxyamphetamine (2,4-DMA), 2,5-dimethoxyamphetamine (2,5-DMA), 2,6-dimethoxyamphetamine (2,6-DMA), and 3,5-dimethoxyamphetamine (3,5-DMA). Other analogues of 3,4-DMA include 3,4-dimethoxyphenethylamine (DMPEA), 3-methoxyamphetamine (3-MA), 4-methoxyamphetamine (PMA), 3,4-ethylenedioxyamphetamine (EDMA), and 3,4-dihydroxyamphetamine (DHA; α-methyldopamine), among others.
== Expression/Production systems == Different organisms may be used to express a gene's target protein, and the expression vector used will therefore have elements specific for use in the particular organism. The most commonly used organism for protein production is the bacterium Escherichia coli. However, not all proteins can be successfully expressed in E. coli, or be expressed with the correct form of post-translational modifications such as glycosylations, and other systems may therefore be used.
== Extraction == Extraction using superheated water tends to be fast because diffusion rates increase with temperature. Organic materials tend to increase in solubility with temperature, but not all at the same rate. For example, in extraction of essential oils from rosemary and coriander, the more valuable oxygenated terpenes were extracted much faster than the hydrocarbons. Therefore, extraction with superheated water can be both selective and rapid, and has been used to fractionate diesel and woodsmoke particulates. Superheated water is being used commercially to extract starch material from marsh mallow root for skincare applications and to remove low levels of metals from a high-temperature resistant polymer. For analytical purposes, superheated water can replace organic solvents in many applications, for example extraction of PAHs from soils and can also be used on a large scale to remediate contaminated soils, by either extraction alone or extraction linked to supercritical or wet oxidation.
We have begun to clear Nuevo Laredo of Zetas because we want a free city and so you can live in peace. We are narcotics traffickers and we don't mess with honest working or business people. I'm going to teach these scums to work Sinaloa style—without kidnapping, without payoffs, without extortion. As for you, 40, I tell you that you don't scare me. I know you sent H to toss heads here in my turf, because you don't have the stones nor the people to do it yourself. Don't forget that I'm your true father. Nuevo Laredo is considered a stronghold of Los Zetas, although there were incursions by the Sinaloa Cartel in March 2012. Consequently, Los Zetas responded two days later with incursions to Sinaloa, the home state of the Sinaloa Cartel. The Sinaloa Cartel's first attempt to take over Nuevo Laredo happened in 2005, when Los Zetas was working as the armed wing of the Gulf Cartel.
Sources: en.wikipedia.org
== Menu == Tim Hortons' first stores offered only two products – coffee and donuts. Aside from its coffee, tea, hot chocolate, and donuts, the menu now contains a number of other baked goods, such as bagels – of which the brand sells one out of every two in the Canadian food service industry. Nutritional information on most menu items is made available by the company in a two-page brochure and online. The brochure does not list ingredient information. Most of the time Tim Hortons' menu contains many of the same items across different locations. However, the pricing may vary since it is a franchise so the cost of each item may be slightly different depending on the owner of the location, as well as the province in which the franchise operates.
suffocating or roasting ants frying, roasting, toasting, suffocating, or drowning crickets eating aphids raw The website Insects Are Food suggests refrigerating insects to slow them down without killing them, prior to boiling or otherwise cooking them. Other guides recommend freezing first. Timothy Ferriss recounts what he observed when roasted his insects without freezing them first: "Suffice it to say, merely sedated crickets make horrible noises if you roast them, and the visual is far, far worse. Do yourself a favor and freeze them."
Looksmaxxing (; LUUKS-MAK-sing) is an online self-improvement practice from the manosphere focused on maximizing one's physical attractiveness. The term is a neologism which was coined on incel message boards in the 2010s. Previously, the phrase had limited usage on obscure internet forums of the incelosphere, but was popularized on TikTok by primarily male content creators in the 2020s. Based on white supremacy, the term has commonly been associated with the black pill ideology, which espouses that female sexual selection is primarily based on external physical qualities such as height and facial attractiveness, while qualities such as kindness and personality are ignored or even cause rejection. Looksmaxxing methods range from benign practices such as skincare routines and gym use, to more extreme interventions such as invasive cosmetic surgery and injection of anabolic steroids, human growth hormone and other peptides. Commentators generally criticize the concept as being judgemental and harmful to its practitioners ("looksmaxxers"). Communities and influencers associated with the practice are described as rating individual's appearance without concern for their overall well-being which can lead to negative mental health outcomes such as body dysmorphia and suicidal ideation. The increasing popularity of the concept has also led to concerns over its potential to promote hegemonic masculinity.
NAD+ + ubiquinol This enzyme is a flavoprotein (FAD). It belongs to the family of oxidoreductases, specifically those acting on NADH or NADPH with other acceptors. The systematic name of this enzyme class is NADH:(quinone-acceptor) oxidoreductase. Other names in common use include reduced nicotinamide adenine dinucleotide (quinone) dehydrogenase, NADH-quinone oxidoreductase, NADH ubiquinone oxidoreductase, DPNH-menadione reductase, D-diaphorase, and NADH2 dehydrogenase (quinone), and mitochondrial (mt) complex I. This enzyme participates in oxidative phosphorylation. Several compounds are known to inhibit this enzyme, including AMP, and 2,4-dinitrophenol. NADH dehydrogenase is involved in the first step of the electron transport chain of oxidative phosphorylation (OXPHOS). Any change in the electron transport component caused by a mutation might effect the normal electron flow. This might be leading "an increase of bifurcation and generation of superoxidase radicals and increase oxidative stress in various types of cancer cells."
For services to Safety at Sea. Derek Baum. For services to the Association of Jewish ex-Servicemen and Women. Donald James MacDonald Beaton, Shepherd, Roslin Institute. For services to Scientific Research. Mary Loveday Beazley. For services to the community in Wormley, Hertfordshire. Marian Beckett, Assistant Caretaker, Priestley College, Warrington, Cheshire. For services to Education. Howard Philip Bell, Honorary Liaison Officer (Eastern Region), Royal National Lifeboat Institution. For services to the RNLI. Clarice Mary Bennett. For services to the British Red Cross Society in Norfolk. Thelma Berry. For services to the Norfolk Foster Care Association. David Wyn Bevan. For services to Industrial Relations in Wales. Mary Winifred Bevan. For services to the NSPCC in Merthyr Tydfil. Deirdre Bevis, Administrative Officer, Ministry of Defence. Fred Billingsley, Higher Professional and Technology Officer, Ministry of Defence. Anthea Billington, Secretary to the Managing Director, Britannia Airways Ltd. For services to the Aviation Industry. Margaret Elizabeth Bingham. For services to Tourism. Jean Shirley Bird, Range B, Her Majesty's Treasury. Edward John Birkett. For services to the community in Canning Town, London. Brian Anthony Blackshaw, Sub-Divisional Officer, West Mercia Special Constabulary. For services to the Police. Mary Elizabeth Bloomer. For services to the community. Christine Boddy. For political service. William Charles Boddy, Founder and Editor, Motor Sport. For services to Sports Journalism. Barbara May Bolton.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.